A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael A. Carducci Tomasz M Beer George Wilding Emmanuel S. Antonarakis Michael J. Morris |
| Publication date | August 4, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |